Index of reports
> Death (29)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mesna death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mesna side effects in female
Reported by a physician from Israel on 2012-08-08
Patient: female, weighing 73.5 kg (161.7 pounds)
Reactions: General Physical Health Deterioration
Adverse event resulted in: death
Drug(s) suspected as cause:
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-17
Etoposide
Dosage: 90mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-07-17
Ifosfamide
Dosage: 1200mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-07-17
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-18
Cytarabine
Dosage: 4mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-19
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-18
Methotrexate
Dosage: 30mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-07-17
Mesna
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-07-17
Possible Mesna side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Mesna side effects in male
Reported by a pharmacist from United States on 2012-06-29
Patient: male, weighing 21.3 kg (46.9 pounds)
Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fludarabine Phosphate
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B-Cell Lymphoma
Start date: 2011-12-27
End date: 2012-01-16
Mesna
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-22
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Other drugs received by patient: Zokzid; Metronidazole; Albuminar-20; Sodium Chloride 0.9%; Diflucan; Meropenem; 5% Glucose; Furosemide
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-19
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Other drugs received by patient: Furosemide; Albuminar-20; Zokzid; Diflucan; 5% Glucose; Meropenem; Metronidazole; Sodium Chloride 0.9%
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-15
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Blood PH Decreased, Haemoglobin Decreased, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Circulatory Collapse, Platelet Count Decreased, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Other drugs received by patient: Diflucan; Albuminar-20; Metronidazole; Zokzid; Meropenem; 5% Glucose; Furosemide; Sodium Chloride 0.9%
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-14
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Other drugs received by patient: Metronidazole; Meropenem; Furosemide; Zokzid; Diflucan; Sodium Chloride 0.9%; Albuminar-20; 5% Glucose
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-12
Patient:
Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Condition Aggravated, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Leukaemia
Leucovorin Calcium
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: days 1-5
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Leukaemia
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: days 1-5
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Prophylaxis
Methylprednisolone
Indication: Prophylaxis
Rituximab
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Leucovorin Calcium
Indication: Burkitt's Leukaemia
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Prophylaxis
Mesna
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Mesna
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Other drugs received by patient: Blood Products; Acyclovir; Antibiotics; Neupogen
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Prophylaxis
Prednisone
Dosage: days 1-5
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Mesna
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Mesna
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Leucovorin Calcium
Indication: Burkitt's Leukaemia
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1
Indication: Burkitt's Lymphoma
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Leukaemia
Prednisone
Dosage: days 1-5
Indication: Burkitt's Leukaemia
Leucovorin Calcium
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Methotrexate
Indication: Prophylaxis
Other drugs received by patient: Neupogen; Acyclovir; Antibiotics; Blood Products
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Methylprednisolone
Indication: Prophylaxis
Mesna
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Cytarabine
Indication: Prophylaxis
Rituximab
Indication: Burkitt's Leukaemia
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Prophylaxis
Mesna
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Leukaemia
Prednisone
Dosage: days 1-5
Indication: Burkitt's Leukaemia
Prednisone
Dosage: days 1-5
Indication: Burkitt's Lymphoma
Leucovorin Calcium
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Leucovorin Calcium
Indication: Burkitt's Lymphoma
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Lymphoma
Other drugs received by patient: Neupogen; Blood Products; Acyclovir; Antibiotics
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08
Patient:
Reactions: Multi-Organ Failure, Tumour Lysis Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: days 4, 5
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 with folinic acid rescue
Indication: Burkitt's Lymphoma
Radiation Therapy NOS
Dosage: 30-36 gy
Indication: Burkitt's Lymphoma
Prednisone
Dosage: days 1-5
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Leucovorin Calcium
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Prophylaxis
Mesna
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4, 5
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Prophylaxis
Dexamethasone
Dosage: on days 1-5
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Other drugs received by patient: Neupogen; Blood Products; Acyclovir; Antibiotics
Possible Mesna side effects in 50 year old male
Reported by a physician from Greece on 2012-05-31
Patient: 50 year old male
Reactions: Multi-Organ Failure, Toxicity To Various Agents
Adverse event resulted in: death
Drug(s) suspected as cause:
Ifosfamide
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Bleomycin Sulfate
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Mesna
Indication: Hodgkin's Disease
Mitoxantrone Hydrochloride
Dacarbazine
Indication: Hodgkin's Disease
Possible Mesna side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient: male, weighing 21.3 kg (46.9 pounds)
Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mesna
Indication: Product Used FOR Unknown Indication
Fludarabine Phosphate
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B-Cell Lymphoma
Start date: 2011-12-27
End date: 2012-01-06
Cytoxan
Indication: Product Used FOR Unknown Indication
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-05-10
Patient:
Reactions: Hypersensitivity, Neurotoxicity, Off Label Use, Hepatotoxicity, Granulocytopenia, Bone Marrow Failure, White Blood Cell Count Decreased, Gastrointestinal Toxicity, Nephropathy Toxic, Urinary Tract Infection, Anaemia, Soft Tissue Infection, Acute Lymphocytic Leukaemia, Sepsis, Platelet Count Decreased, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Mesna
Indication: Acute Myeloid Leukaemia
Methotrexate
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Mesna
Indication: non-Hodgkin's Lymphoma
Vindesine
Indication: Acute Lymphocytic Leukaemia
Vindesine
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Dexamethasone TAB
Indication: non-Hodgkin's Lymphoma
Dexamethasone TAB
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Leucovorin Calcium
Possible Mesna side effects in 50 year old male
Reported by a physician from Greece on 2012-05-02
Patient: 50 year old male
Reactions: Multi-Organ Failure, Toxicity To Various Agents
Adverse event resulted in: death
Drug(s) suspected as cause:
Mitoxantrone Hydrochloride
Etoposide
Indication: Hodgkin's Disease
Mesna
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Bleomycin
Indication: Hodgkin's Disease
Vinblastine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Possible Mesna side effects in
Reported by a physician from Norway on 2012-02-29
Patient:
Reactions: Off Label Use, Nephropathy Toxic
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Doxorubicin HCL
Indication: Sarcoma
Ifosfamide
Indication: Sarcoma
Ifosfamide
Ifosfamide
Mesna
Doxorubicin HCL
Mesna
Indication: Sarcoma
Mesna
Radiation Therapy NOS
Indication: Sarcoma
Possible Mesna side effects in
Reported by a physician from Norway on 2012-02-29
Patient:
Reactions: Off Label Use, Blood Creatinine Abnormal
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Ifosfamide
Indication: Sarcoma
Radiation Therapy NOS
Indication: Sarcoma
Doxorubicin HCL
Ifosfamide
Mesna
Mesna
Indication: Sarcoma
Ifosfamide
Doxorubicin HCL
Indication: Sarcoma
Mesna
Possible Mesna side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-23
Patient: 61 year old female
Reactions: Urinary Tract Infection, Encephalopathy, Meningitis, Septic Shock, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Zofran
Dosage: 8mg/day
Start date: 2011-12-05
End date: 2011-12-06
Solu-Medrol
Dosage: 40mg/day
Indication: Chemotherapy
Start date: 2011-12-05
End date: 2011-12-06
Ifosfamide
Dosage: 4160mg/day
Indication: Chemotherapy
Start date: 2011-12-05
End date: 2011-12-06
Mesna
Dosage: 1300 mg, 3x/day
Indication: Chemotherapy
Start date: 2011-12-05
End date: 2011-12-06
Emend
Dosage: 80mg/day
Administration route: Oral
Indication: Chemotherapy
Start date: 2011-12-05
End date: 2011-12-06
Other drugs received by patient: Lyrica; Duragesic-100; Oxycodone HCL; Lyrica
Possible Mesna side effects in 60 year old male
Reported by a physician from Korea, Democratic People's Republic of on 2012-02-10
Patient: 60 year old male
Reactions: Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrexate
Etoposide
Indication: Lymphoma
Prednisolone
Dosage: 300 mg
Administration route: Oral
Indication: Lymphoma
Ifosfamide
Indication: Lymphoma
Mesna
Indication: Lymphoma
Methotrexate
Indication: Lymphoma
Hydrocortisone
Indication: Lymphoma
Cytarabine
Indication: Lymphoma
Possible Mesna side effects in 59 year old female
Reported by a physician from Korea, Democratic People's Republic of on 2012-02-10
Patient: 59 year old female
Reactions: Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 300 mg
Administration route: Oral
Indication: Lymphoma
Methotrexate
Cytarabine
Indication: Lymphoma
Hydrocortisone
Indication: Lymphoma
Ifosfamide
Indication: Lymphoma
Methotrexate
Indication: Lymphoma
Etoposide
Indication: Lymphoma
Mesna
Indication: Lymphoma
Possible Mesna side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-23
Patient: 65 year old male
Reactions: Multi-Organ Failure, Lung Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Busulfan
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-12-02
End date: 2011-12-04
Cyclophosphamide
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-12-05
End date: 2011-12-06
Thiotepa
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-11-29
End date: 2011-12-01
Mesna
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-05
End date: 2011-12-06
Other drugs received by patient: Clonazepam
Possible Mesna side effects in 36 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-09
Patient: 36 year old male
Reactions: Cardiac Tamponade, Hypotension, Tachycardia, Diastolic Dysfunction, Myopericarditis, Systolic Dysfunction, Sepsis, Cardiac Arrest, Anuria
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Metoclopramide
Dosage: 3 unit
Start date: 2011-03-05
End date: 2011-03-06
Gentamicin Sulfate
Dosage: 300 mg, unk
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-06
Cyclophosphamide
Dosage: 3200 mg, unk
Start date: 2011-03-01
End date: 2011-03-04
Fondaparinux Sodium
Carboplatin
Dosage: 899 mg, unk
Start date: 2011-03-01
End date: 2011-03-04
Morphine
Dosage: unk
Start date: 2011-03-05
End date: 2011-03-06
Amifostine
Dosage: 2 unit
Start date: 2011-03-01
End date: 2011-03-04
Mesna
Dosage: 800 mg, unk
Start date: 2011-03-01
End date: 2011-03-04
Etoposide
Dosage: 900 mg, unk
Start date: 2011-03-01
End date: 2011-03-04
Acyclovir
Dosage: 750 mg, unk
Start date: 2011-03-05
End date: 2011-03-06
Amikacin
Dosage: 1300 mg, unk
Start date: 2011-03-04
End date: 2011-03-05
Piperacillin and Tazobactam
Dosage: 12 g, unk
Start date: 2011-03-04
End date: 2011-03-06
Other drugs received by patient: Prednisolone; Levetiracetam; Clonazepam; Esomeprazole; Pregabalin
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31
Patient:
Reactions: Sudden Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Lymphoma
Doxorubicin HCL
Cyclophosphamide
Cyclophosphamide
Bleomycin Sulfate
Indication: Lymphoma
Bleomycin Sulfate
Methotrexate
Indication: Lymphoma
Cytarabine
Indication: Lymphoma
Doxorubicin HCL
Cyclophosphamide
Indication: Lymphoma
Eldisine
Bleomycin Sulfate
Cytarabine
Methotrexate
Ifosfamide
Mesna
Eldisine
Prednisone
Administration route: Oral
Indication: Lymphoma
Ifosfamide
Indication: Lymphoma
Cyclophosphamide
Mesna
Eldisine
Indication: Lymphoma
Eldisine
Methotrexate
Etoposide
Indication: Lymphoma
Ifosfamide
Doxorubicin HCL
Mesna
Indication: Lymphoma
Mesna
Bleomycin Sulfate
Ifosfamide
Other drugs received by patient: Neupogen
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31
Patient:
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Cyclophosphamide
Eldisine
Eldisine
Ifosfamide
Indication: Lymphoma
Cyclophosphamide
Cyclophosphamide
Mesna
Ifosfamide
Etoposide
Cytarabine
Indication: Lymphoma
Cytarabine
Eldisine
Bleomycin Sulfate
Indication: Lymphoma
Bleomycin Sulfate
Etoposide
Mesna
Eldisine
Indication: Lymphoma
Bleomycin Sulfate
Methotrexate
Doxorubicin HCL
Mesna
Bleomycin Sulfate
Ifosfamide
Ifosfamide
Etoposide
Indication: Lymphoma
Etoposide
Cytarabine
Doxorubicin HCL
Indication: Lymphoma
Doxorubicin HCL
Doxorubicin HCL
Mesna
Indication: Lymphoma
Prednisone
Administration route: Oral
Indication: Lymphoma
Methotrexate
Indication: Lymphoma
Methotrexate
Cytarabine
Other drugs received by patient: Neupogen
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31
Patient:
Reactions: Cardiac Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Eldisine
Indication: Lymphoma
Eldisine
Bleomycin Sulfate
Cyclophosphamide
Mesna
Methotrexate
Indication: Lymphoma
Mesna
Indication: Lymphoma
Prednisone
Administration route: Oral
Indication: Lymphoma
Etoposide
Indication: Lymphoma
Ifosfamide
Doxorubicin HCL
Doxorubicin HCL
Doxorubicin HCL
Cyclophosphamide
Indication: Lymphoma
Cyclophosphamide
Mesna
Methotrexate
Ifosfamide
Indication: Lymphoma
Ifosfamide
Eldisine
Bleomycin Sulfate
Bleomycin Sulfate
Cytarabine
Indication: Lymphoma
Bleomycin Sulfate
Indication: Lymphoma
Ifosfamide
Doxorubicin HCL
Indication: Lymphoma
Cyclophosphamide
Mesna
Eldisine
Cytarabine
Methotrexate
Other drugs received by patient: Leucovorin Calcium; Neupogen
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31
Patient:
Reactions: Toxicity To Various Agents, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Cyclophosphamide
Mesna
Eldisine
Indication: Lymphoma
Eldisine
Eldisine
Bleomycin Sulfate
Methotrexate
Indication: Lymphoma
Bleomycin Sulfate
Doxorubicin HCL
Indication: Lymphoma
Eldisine
Bleomycin Sulfate
Indication: Lymphoma
Cyclophosphamide
Mesna
Prednisone
Administration route: Oral
Indication: Lymphoma
Cyclophosphamide
Indication: Lymphoma
Mesna
Indication: Lymphoma
Mesna
Bleomycin Sulfate
Doxorubicin HCL
Doxorubicin HCL
Cyclophosphamide
Other drugs received by patient: Neupogen
Possible Mesna side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Eldisine
Eldisine
Indication: Lymphoma
Ifosfamide
Indication: Lymphoma
Doxorubicin HCL
Doxorubicin HCL
Eldisine
Prednisone
Administration route: Oral
Indication: Lymphoma
Bleomycin Sulfate
Cytarabine
Indication: Lymphoma
Cyclophosphamide
Mesna
Mesna
Eldisine
Bleomycin Sulfate
Methotrexate
Indication: Lymphoma
Etoposide
Indication: Lymphoma
Ifosfamide
Doxorubicin HCL
Cytarabine
Cyclophosphamide
Indication: Lymphoma
Cyclophosphamide
Cyclophosphamide
Mesna
Indication: Lymphoma
Mesna
Doxorubicin HCL
Indication: Lymphoma
Bleomycin Sulfate
Indication: Lymphoma
Bleomycin Sulfate
Methotrexate
Methotrexate
Ifosfamide
Ifosfamide
Other drugs received by patient: Leucovorin Calcium; Neupogen
Possible Mesna side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-25
Patient: female
Reactions: Death, Febrile Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Sarcoma Uterus
Mesna
Indication: Sarcoma Uterus
Cisplatin
Indication: Sarcoma Uterus
Ifosfamide
Indication: Sarcoma Uterus
Lenograstim
Indication: Sarcoma Uterus
Possible Mesna side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-24
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Sarcoma Uterus
Lenograstim
Indication: Sarcoma Uterus
Doxorubicin HCL
Indication: Sarcoma Uterus
Ifosfamide
Indication: Sarcoma Uterus
Mesna
Indication: Sarcoma Uterus
|